Registro:

Referencias:

• Dong, Z., Bonfil, R.D., Chinni, S., Deng, X., Trindade Filho, J.C., Bernardo, M., Vaishampayan, U., Cher, M.L., Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue (2005) Am. J. Pathol., 166 (4), pp. 1173-1186
• Gupta, G.P., Minn, A.J., Kang, Y., Siegel, P.M., Serganova, I., Cordon-Cardo, C., Olshen, A.B., Massague, J., Identifying site-specific metastasis genes and functions (2005) Cold Spring Harb. Symp. Quant. Biol., 70, pp. 149-158
• Fidler, I.J., The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited (2003) Nat. Rev. Cancer., 3 (6), pp. 453-458
• Weigelt, B., Peterse, J.L., van 't Veer, L.J., Breast cancer metastasis: Markers and models (2005) Nat. Rev. Cancer., 5 (8), pp. 591-602
• Gupta, G.P., Massague, J., Cancer metastasis: Building a framework (2006) Cell, 127 (4), pp. 679-695
• Bell, D.W., Our changing view of the genomic landscape of cancer (2010) J. Pathol., 220 (2), pp. 231-243
• Hanahan, D., Weinberg, R.A., The hallmarks of cancer (2000) Cell, 100 (1), pp. 57-70
• Mantovani, A., Cancer: Inflaming metastasis (2009) Nature, 457 (7225), pp. 36-37
• Chenau, J., Michelland, S., de Fraipont, F., Josserand, V., Coll, J.L., Favrot, M.C., Seve, M., The cell line secretome, a suitable tool for investigating proteins released in vivo by tumors: Application to the study of p53-modulated proteins secreted in lung cancer cells (2009) J. Proteome. Res., 8 (10), pp. 4579-4591
• Mehrotra, S., Languino, L.R., Raskett, C.M., Mercurio, A.M., Dohi, T., Altieri, D.C., IAP regulation of metastasis (2010) Cancer Cell, 17 (1), pp. 53-64
• Spano, D., Russo, R., Di Maso, V., Rosso, N., Terracciano, L.M., Roncalli, M., Tornillo, L., Iolascon, A., Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness (2010) Mol. Med., 16 (3-4), pp. 102-115
• Schultz, J., Koczan, D., Schmitz, U., Ibrahim, S.M., Pilch, D., Landsberg, J., Kunz, M., Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth (2010) Clin. Exp. Metastasis., 27 (3), pp. 133-140
• Matsuyama, T., Ishikawa, T., Mogushi, K., Yoshida, T., Iida, S., Uetake, H., Mizushima, H., Sugihara, K., MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer (2010) Int. J. Cancer., 127 (10), pp. 2292-2299
• Hao, J.M., Chen, J.Z., Sui, H.M., Si-Ma, X.Q., Li, G.Q., Liu, C., Li, J.L., Li, J.M., A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer (2010) J. Pathol., 220 (4), pp. 475-489
• Muller, T., Stein, U., Poletti, A., Garzia, L., Rothley, M., Plaumann, D., Thiele, W., Sleeman, J.P., ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients (2010) Oncogene, 29 (16), pp. 2393-2403
• Hong, Y., Downey, T., Eu, K.W., Koh, P.K., Cheah, P.Y., A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics (2010) Clin. Exp. Metastasis., 27 (2), pp. 83-90
• Logothetis, C.J., Lin, S.H., Osteoblasts in prostate cancer metastasis to bone (2005) Nat. Rev. Cancer., 5 (1), pp. 21-28
• Li, Z.G., Yang, J., Vazquez, E.S., Rose, D., Vakar-Lopez, F., Mathew, P., Lopez, A., Navone, N.M., Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone (2008) Oncogene, 27 (5), pp. 596-603
• Chambers, A.F., Groom, A.C., Macdonald, I.C., Dissemination and growth of cancer cells in metastatic sites (2002) Nat. Rev. Cancer., 2 (8), pp. 563-572
• Dittmar, T., Heyder, C., Gloria-Maercker, E., Hatzmann, W., Zanker, K.S., Adhesion molecules and chemokines: The navigation system for circulating tumor (stem) cells to metastasize in an organ- specific manner (2008) Clin. Exp. Metastasis., 25 (1), pp. 11-32
• Qiu, H., Orr, F.W., Jensen, D., Wang, H.H., McIntosh, A.R., Hasinoff, B.B., Nance, D.M., Al-Mehdi, A.B., Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells (2003) Am. J. Pathol., 162 (2), pp. 403-412
• Hall, K., Ran, S., Regulation of tumor angiogenesis by the local environment (2010) Front. Biosci., 15, pp. 195-212
• Vicari, A.P., Caux, C., Chemokines in cancer (2002) Cytokine Growth Factor Rev, 13 (2), pp. 143-154
• Pratap, J., Javed, A., Languino, L.R., van Wijnen, A.J., Stein, J.L., Stein, G.S., Lian, J.B., The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion (2005) Mol. Cell Biol., 25 (19), pp. 8581-8591
• de Marzo, A.M., Platz, E.A., Sutcliffe, S., Xu, J., Gronberg, H., Drake, C.G., Nakai, Y., Nelson, W.G., Inflammation in prostate carcinogenesis (2007) Nat. Rev. Cancer., 7 (4), pp. 256-269
• Gueron, G., de Siervi, A., Ferrando, M., Salierno, M., de Luca, P., Elguero, B., Meiss, R., Vazquez, E.S., Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells (2009) Mol. Cancer Res., 7 (11), pp. 1745-1755
• Jozkowicz, A., Was, H., Dulak, J., Heme oxygenase-1 in tumors: Is it a false friend? (2007) Antioxid Redox Signal, 9 (12), pp. 2099-2117
• Ran, S., Volk, L., Hall, K., Flister, M.J., Lymphangiogenesis and lymphatic metastasis in breast cancer (2009) Pathophysiology, 7 (4), pp. 229-251
• Liu, Y., Ji, R., Li, J., Gu, Q., Zhao, X., Sun, T., Wang, J., Sun, B., Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis (2010) J. Exp. Clin. Cancer Res., 29 (1), p. 16
• Zlotnik, A., Chemokines in neoplastic progression (2004) Semin. Cancer Biol., 14 (3), pp. 181-185
• Zhang, S., Qi, L., Li, M., Zhang, D., Xu, S., Wang, N., Sun, B., Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer (2008) J. Exp. Clin. Cancer Res., 27, p. 62
• Saigusa, S., Toiyama, Y., Tanaka, K., Yokoe, T., Okugawa, Y., Kawamoto, A., Yasuda, H., Kusunoki, M., Stromal CXCR4 and CXCL12 expression is associated with distant recurrence and poor prognosis in rectal cancer after chemoradiotherapy (2010) Ann. Surg. Oncol., 17 (8), pp. 2051-2058
• Lazennec, G., Richmond, A., Chemokines and chemokine receptors: New insights into cancer-related inflammation (2010) Trends Mol. Med., 16 (3), pp. 133-144
• Zabuawala, T., Taffany, D.A., Sharma, S.M., Merchant, A., Adair, B., Srinivasan, R., Rosol, T.J., Ostrowski, M.C., An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis (2010) Cancer Res, 70 (4), pp. 1323-1333
• Utispan, K., Thuwajit, P., Abiko, Y., Charngkaew, K., Paupairoj, A., Chau-In, S., Thuwajit, C., Gene expression profiling of cholangiocarcinoma- derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker (2010) Mol. Cancer., 9, p. 13
• McConkey, D.J., Choi, W., Marquis, L., Martin, F., Williams, M.B., Shah, J., Svatek, R., Dinney, C., Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer (2009) Cancer Metastasis Rev, 28 (3-4), pp. 335-344
• Acloque, H., Thiery, J.P., Nieto, M.A., The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition (2008) EMBO Rep, 9 (4), pp. 322-326
• Kalluri, R., Weinberg, R.A., The basics of epithelial-mesenchymal transition (2009) J. Clin. Invest, 119 (6), pp. 1420-1428
• Hader, C., Marlier, A., Cantley, L., Mesenchymal-epithelial transition in epithelial response to injury: The role of Foxc2 (2010) Oncogene, 29 (7), pp. 1031-1040
• Kang, Y., Massague, J., Epithelial-mesenchymal transitions: Twist in development and metastasis (2004) Cell, 118 (3), pp. 277-279
• Jaggi, M., Johansson, S.L., Baker, J.J., Smith, L.M., Galich, A., Balaji, K.C., Aberrant expression of E-cadherin and beta-catenin in human prostate cancer (2005) Urol. Oncol., 23 (6), pp. 402-406
• Gravdal, K., Halvorsen, O.J., Haukaas, S.A., Akslen, L.A., A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer (2007) Clin. Cancer Res., 13 (23), pp. 7003-7011
• Xie, D., Gore, C., Liu, J., Pong, R.C., Mason, R., Hao, G., Long, M., Hsieh, J.T., Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis (2010) Proc. Natl. Acad. Sci. USA., 107 (6), pp. 2485-2490
• Gjerdrum, C., Tiron, C., Hoiby, T., Stefansson, I., Haugen, H., Sandal, T., Collett, K., Lorens, J.B., Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival (2010) Proc. Natl. Acad. Sci. USA., 107 (3), pp. 1124-1129
• Iwatsuki, M., Mimori, K., Yokobori, T., Ishi, H., Beppu, T., Nakamori, S., Baba, H., Mori, M., Epithelial-mesenchymal transition in cancer development and its clinical significance (2010) Cancer Sci, 101 (2), pp. 293-299
• McCoy, E.L., Iwanaga, R., Jedlicka, P., Abbey, N.S., Chodosh, L.A., Heichman, K.A., Welm, A.L., Ford, H.L., Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition (2009) J. Clin. Invest., 119 (9), pp. 2663-2677
• Micalizzi, D.S., Christensen, K.L., Jedlicka, P., Coletta, R.D., Baron, A.E., Harrell, J.C., Horwitz, K.B., Ford, H.L., The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling (2009) J. Clin. Invest., 119 (9), pp. 2678-2690
• Choi, Y.L., Bocanegra, M., Kwon, M.J., Shin, Y.K., Nam, S.J., Yang, J.H., Kao, J., Pollack, J.R., LYN Is a Mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer (2010) Cancer Res, 70 (6), pp. 2296-2306
• Yan, W., Cao, Q.J., Arenas, R.B., Bentley, B., Shao, R., GATA3 inhibits breast cancer metastasis through the reversal of epithelialmesenchymal transition (2010) J. Biol. Chem., 285 (18), pp. 14042-14051
• Jung, H., Lee, K.P., Park, S.J., Park, J.H., Jang, Y.S., Choi, S.Y., Jung, J.G., Park, Y.W., TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition (2008) Oncogene, 27 (18), pp. 2635-2647
• Tang, D.J., Dong, S.S., Ma, N.F., Xie, D., Chen, L., Fu, L., Lau, S.H., Guan, X.Y., Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma (2009) Hepatology, 51 (4), pp. 1255-1263
• Yang, M.H., Chen, C.L., Chau, G.Y., Chiou, S.H., Su, C.W., Chou, T.Y., Peng, W.L., Wu, J.C., Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma (2009) Hepatology, 50 (5), pp. 1464-1474
• Lenferink, A.E., Cantin, C., Nantel, A., Wang, E., Durocher, Y., Banville, M., Paul-Roc, B., O'connor-McCourt, M.D., Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies (2010) Oncogene, 29 (6), pp. 831-844
• Zhu, M.L., Kyprianou, N., Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells (2010) FASEB J, 24 (3), pp. 769-777
• Harris, A.L., Hypoxia--a key regulatory factor in tumour growth (2002) Nat. Rev. Cancer., 2 (1), pp. 38-47
• Bertout, J.A., Patel, S.A., Simon, M.C., The impact of O2 availability on human cancer (2008) Nat. Rev. Cancer., 8 (12), pp. 967-975
• Yang, M.H., Wu, K.J., TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development (2008) Cell Cycle, 7 (14), pp. 2090-2096
• Huang, C.H., Yang, W.H., Chang, S.Y., Tai, S.K., Tzeng, C.H., Kao, J.Y., Wu, K.J., Yang, M.H., Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxiamediated metastasis (2009) Neoplasia, 11 (12), pp. 1371-1382
• Lundgren, K., Nordenskjold, B., Landberg, G., Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer (2009) Br. J. Cancer., 101 (10), pp. 1769-1781
• Maniotis, A.J., Folberg, R., Hess, A., Seftor, E.A., Gardner, L.M., Pe'er, J., Trent, J.M., Hendrix, M.J., Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry (1999) Am. J. Pathol., 155 (3), pp. 739-752
• Folberg, R., Hendrix, M.J., Maniotis, A.J., Vasculogenic mimicry and tumor angiogenesis (2000) Am. J. Pathol., 156 (2), pp. 361-381
• Sharma, N., Seftor, R.E., Seftor, E.A., Gruman, L.M., Heidger Jr., P.M., Cohen, M.B., Lubaroff, D.M., Hendrix, M.J., Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: Role in vasculogenic mimicry (2002) Prostate, 50 (3), pp. 189-201
• Shirakawa, K., Kobayashi, H., Heike, Y., Kawamoto, S., Brechbiel, M.W., Kasumi, F., Iwanaga, T., Wakasugi, H., Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft (2002) Cancer Res, 62 (2), pp. 560-566
• Sood, A.K., Seftor, E.A., Fletcher, M.S., Gardner, L.M., Heidger, P.M., Buller, R.E., Seftor, R.E., Hendrix, M.J., Molecular determinants of ovarian cancer plasticity (2001) Am. J. Pathol., 158 (4), pp. 1279-1288
• Sun, B., Qie, S., Zhang, S., Sun, T., Zhao, X., Gao, S., Ni, C., Zhang, L., Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors (2008) Hum. Pathol., 39 (3), pp. 444-451
• Li, M., Gu, Y., Zhang, Z., Zhang, S., Zhang, D., Saleem, A.F., Zhao, X., Sun, B., Vasculogenic mimicry: A new prognostic sign of gastric adenocarcinoma (2009) Pathol. Oncol. Res., 16 (2), pp. 259-266
• Sun, T., Zhao, N., Zhao, X.L., Gu, Q., Zhang, S.W., Che, N., Wang, X.H., Sun, B.C., Expression and functional significance of Twist1 in hepatocellular carcinoma: Its role in vasculogenic mimicry (2010) Hepatology, 51 (2), pp. 545-556
• Zhao, X.L., Sun, T., Che, N., Sun, D., Zhao, N., Dong, X.Y., Gu, Q., Sun, B.C., Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelialmesenchymal transition regulator twist1 (2010) J. Cell Mol. Med., , Epub ahead of print
• Mourad-Zeidan, A.A., Melnikova, V.O., Wang, H., Raz, A., Bar-Eli, M., Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry (2008) Am. J. Pathol., 173 (6), pp. 1839-1852
• Hart, I.R., New evidence for tumour embolism as a mode of metastasis (2009) J. Pathol., 219 (3), pp. 275-276
• Kats-Ugurlu, G., Roodink, I., de Weijert, M., Tiemessen, D., Maass, C., Verrijp, K., van der Laak, J., Leenders, W., Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma (2009) J. Pathol., 219 (3), pp. 287-293
• Reddy, S.D., Gajula, R.P., Pakala, S.B., Kumar, R., MicroRNAs and cancer therapy: The next wave or here to stay? (2010) Cancer Biol. Ther., 9 (7), pp. 479-482
• Cho, W.C., MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy (2009) Int. J. Biochem. Cell Biol., 42 (8), pp. 1273-1281
• Calin, G.A., Sevignani, C., Dumitru, C.D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Croce, C.M., Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers (2004) Proc. Natl. Acad. Sci. USA., 101 (9), pp. 2999-3004
• Zhang, H., Li, Y., Lai, M., The microRNA network and tumor metastasis (2010) Oncogene, 29 (7), pp. 937-948
• Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Weinberg, R.A., miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis (2010) Nat. Cell Biol., 12 (3), pp. 247-256
• Guo, J., Dong, Q., Fang, Z., Chen, X., Lu, H., Wang, K., Yin, Y., Zhang, C.Y., Identification of miRNAs that are associated with tumor metastasis in neuroblastoma (2010) Cancer Biol. Ther., 9 (6), pp. 446-452
• Kitago, M., Martinez, S.R., Nakamura, T., Sim, M.S., Hoon, D.S., Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma (2009) Clin. Cancer Res., 15 (9), pp. 2988-2994
• Friedman, J.M., Liang, G., Liu, C.C., Wolff, E.M., Tsai, Y.C., Ye, W., Zhou, X., Jones, P.A., The putative tumor suppressor microRNA-101 modulates the cancer epigenome by repressing the polycomb group protein EZH2 (2009) Cancer Res, 69 (6), pp. 2623-2629
• Li, S., Fu, H., Wang, Y., Tie, Y., Xing, R., Zhu, J., Sun, Z., Zheng, X., MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma (2009) Hepatology, 49 (4), pp. 1194-1202
• Reddy, S.D., Pakala, S.B., Ohshiro, K., Rayala, S.K., Kumar, R., MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions (2009) Cancer Res, 69 (14), pp. 5639-5642
• Hurst, D.R., Edmonds, M.D., Scott, G.K., Benz, C.C., Vaidya, K.S., Welch, D.R., Breast cancer metastasis suppressor 1 upregulates miR-146, which suppresses breast cancer metastasis (2009) Cancer Res, 69 (4), pp. 1279-1283
• Tsai, W.C., Hsu, P.W., Lai, T.C., Chau, G.Y., Lin, C.W., Chen, C.M., Lin, C.D., Tsou, A.P., MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma (2009) Hepatology, 49 (5), pp. 1571-1582
• Zbytek, B., Carlson, J.A., Granese, J., Ross, J., Mihm, M.C., Slominski, A., Current concepts of metastasis in melanoma (2008) Exp. Rev. Dermatol., 3 (5), pp. 569-585
• Mahmoud, W., Sukhanova, A., Oleinikov, V., Rakovich, Y.P., Donegan, J.F., Pluot, M., Cohen, J.H., Nabiev, I., Emerging applications of fluorescent nanocrystals quantum dots for micrometastases detection (2010) Proteomics, 10 (4), pp. 700-716
• Gonda, K., Watanabe, T.M., Ohuchi, N., Higuchi, H., In vivo nanoimaging of membrane dynamics in metastatic tumor cells using quantum dots (2010) J. Biol. Chem., 285 (4), pp. 2750-2757
• Yang, K., Li, Z., Cao, Y., Yu, X., Mei, J., Effect of peptideconjugated near-infrared fluorescent quantum dots (NIRF-QDs) on the invasion and metastasis of human tongue squamous cell carcinoma cell line Tca8113 in Vitro (2009) Int. J. Mol. Sci., 10 (10), pp. 4418-4427
• Kobayashi, H., Ogawa, M., Kosaka, N., Choyke, P.L., Urano, Y., Multicolor imaging of lymphatic function with two nanomaterials: Quantum dot-labeled cancer cells and dendrimer-based optical agents (2009) Nanomedicine (Lond), 4 (4), pp. 411-419
• Zhang, H., Zeng, X., Li, Q., Gaillard-Kelly, M., Wagner, C.R., Yee, D., Fluorescent tumour imaging of type I IGF receptor in vivo: Comparison of ntibody-conjugated quantum dots and smallmolecule fluorophore (2009) Br. J. Cancer., 101 (1), pp. 71-79
• Choi, J., Burns, A.A., Williams, R.M., Zhou, Z., Flesken-Nikitin, A., Zipfel, W.R., Wiesner, U., Nikitin, A.Y., Core-shell silica nanoparticles as fluorescent labels for nanomedicine (2007) J. Biomed. Opt., 12 (6). , 064007
• Derfus, A.M., Chen, A.A., Min, D.H., Ruoslahti, E., Bhatia, S.N., Targeted quantum dot conjugates for siRNA delivery (2007) Bioconjug. Chem., 18 (5), pp. 1391-1396
• Gao, X., Chung, L.W., Nie, S., Quantum dots for in vivo molecular and cellular imaging (2007) Methods Mol. Biol., 374, pp. 135-145
• Rhodes, D.R., Chinnaiyan, A.M., Integrative analysis of the cancer transcriptome (2005) Nat. Genet., 37 (SUPPL.), pp. 31-37
• Dutertre, M., Lacroix-Triki, M., Driouch, K., de la Grange, P., Gratadou, L., Beck, S., Millevoi, S., Auboeuf, D., Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis (2010) Cancer Res, 70 (3), pp. 896-905
• Rickman, D.S., Millon, R., de Reynies, A., Thomas, E., Wasylyk, C., Muller, D., Abecassis, J., Wasylyk, B., Prediction of future metastasis and molecular characterization of head and neck squamouscell carcinoma based on transcriptome and genome analysis by microarrays (2008) Oncogene, 27 (51), pp. 6607-6622
• Pascal, L.E., Vencio, R.Z., Page, L.S., Liebeskind, E.S., Shadle, C.P., Troisch, P., Marzolf, B., Liu, A.Y., Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes (2009) BMC Cancer, 9, p. 452
• Bafico, A., Liu, G., Goldin, L., Harris, V., Aaronson, S.A., An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells (2004) Cancer Cell, 6 (5), pp. 497-506
• Tahara, T., Shibata, T., Arisawa, T., Nakamura, M., Yamashita, H., Yoshioka, D., Okubo, M., Hirata, I., CpG island promoter methylation (CIHM) status of tumor suppressor genes correlates with morphological appearances of gastric cancer (2010) Anticancer Res, 30 (1), pp. 239-244
• la Merrill, M., Gordon, R.R., Hunter, K.W., Threadgill, D.W., Pomp, D., Dietary fat alters pulmonary metastasis of mammary cancers through cancer autonomous and non-autonomous changes in gene expression (2010) Clin. Exp. Metastasis., 27 (2), pp. 107-116
• Bojovic, B., Crowe, D.L., Chronologic aging decreases tumor angiogenesis and metastasis in a mouse model of head and neck cancer (2010) Int. J. Oncol., 36 (3), pp. 715-723
• Hsu, P.P., Sabatini, D.M., Cancer cell metabolism: Warburg and beyond (2008) Cell, 134 (5), pp. 703-707
• Declerck, K., Elble, R.C., The role of hypoxia and acidosis in promoting metastasis and resistance to chemotherapy (2010) Front Biosci, 15, pp. 213-225
• Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Thun, M.J., Cancer statistics, 2009 (2009) CA Cancer J. Clin., 59 (4), pp. 225-249
• Vogiatzi, P., Cassone, M., Claudio, L., Claudio, P.P., Targeted therapy for advanced prostate cancer: Looking through new lenses (2009) Drug News Perspect, 22 (10), pp. 593-601
• Li, Z.G., Mathew, P., Yang, J., Starbuck, M.W., Zurita, A.J., Liu, J., Sikes, C., Navone, N.M., Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms (2008) J. Clin. Invest., 118 (8), pp. 2697-2710
• Min, J., Zaslavsky, A., Fedele, G., McLaughlin, S.K., Reczek, E.E., de Raedt, T., Guney, I., Cichowski, K., An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB Nat. Med., 16 (3), pp. 286-294
• Simon, J.A., Lange, C.A., Roles of the EZH2 histone methyltransferase in cancer epigenetics (2008) Mutat. Res., 647 (1-2), pp. 21-29
• Reijm, E.A., Jansen, M.P., Ruigrok-Ritstier, K., van Staveren, I.L., Look, M.P., van Gelder, M.E., Sieuwerts, A.M., Berns, E.M., Decreased expression of EZH2 is associated with upregulation of ER and favorable outcome to tamoxifen in advanced breast cancer (2010) Breast Cancer Res. Treat., , Epub ahead of print
• Lewis Phillips, G.D., Li, G., Dugger, D.L., Crocker, L.M., Parsons, K.L., Mai, E., Blattler, W.A., Sliwkowski, M.X., Targeting HER2-positive breast cancer with trastuzumab-DM1, an ntibody-cytotoxic drug conjugate (2008) Cancer Res, 68 (22), pp. 9280-9290
• Zhang, G., Zhang, H., Wang, Q., Lal, P., Carroll, A.M., de la Llera-Moya, M., Xu, X., Greene, M.I., Suppression of human prostate tumor growth by a unique prostate-specific monoclonal antibody F77 targeting a glycolipid marker (2010) Proc. Natl. Acad. Sci. USA., 107 (2), pp. 732-737
• Oussedik, K., Francois, J.C., Halby, L., Senamaud-Beaufort, C., Toutirais, G., Dallavalle, S., Pommier, Y., Arimondo, P.B., Sequence specific targeting of IGF-I and IGF-IR genes by camptothecins (2010) FASEB J, 24 (7), pp. 2235-2244
• Kim, S.Y., Helman, L.J., Strategies to explore new approaches in the investigation and treatment of osteosarcoma (2010) Cancer Treat. Res., 152, pp. 517-528
• Aizawa, J., Sakayama, K., Kamei, S., Kidani, T., Yamamoto, H., Norimatsu, Y., Masuno, H., Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8 (2010) BMC Cancer, 10, p. 51
• Arora, A., Scholar, E.M., Role of tyrosine kinase inhibitors in cancer therapy (2005) J. Pharmacol. Exp. Ther., 315 (3), pp. 971-979
• Merlos-Suarez, A., Batlle, E., Eph-ephrin signalling in adult tissues and cancer (2008) Curr. Opin. Cell Biol., 20 (2), pp. 194-200
• Ruan, J., Martin, P., Coleman, M., Furman, R.R., Cheung, K., Faye, A., Elstrom, R., Leonard, J.P., Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma (2010) Cancer, 116 (11), pp. 2655-2664
• Sharom, F.J., ABC multidrug transporters: Structure, function and role in chemoresistance (2008) Pharmacogenomics, 9 (1), pp. 105-127
• Lee, C.H., Reversing agents for ATP-binding cassette drug transporters (2010) Methods Mol. Biol., 596, pp. 325-340
• Li, C., Chen, S., Yue, P., Deng, X., Lonial, S., Khuri, F.R., Sun, S.Y., The proteasome inhibitor PS-341 (Bortezomib) induces calpain-dependent I{kappa}B{alpha} degradation (2010) J. Biol. Chem., 285 (21), pp. 16096-16104
• Peacock, C.D., Wang, Q., Gesell, G.S., Corcoran-Schwartz, I.M., Jones, E., Kim, J., Devereux, W.L., Matsui, W., Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma (2007) Proc. Natl. Acad. Sci. USA., 104 (10), pp. 4048-4053
• Robarge, K.D., Brunton, S.A., Castanedo, G.M., Cui, Y., Dina, M.S., Goldsmith, R., Gould, S.E., Xie, M., GDC-0449-a potent inhibitor of the hedgehog pathway (2009) Bioorg. Med. Chem. Lett., 19 (19), pp. 5576-5581
• Peukert, S., Miller-Moslin, K., Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics (2010) Chem. Med. Chem., 5 (4), pp. 500-512
• Ladoire, S., Arnould, L., Mignot, G., Coudert, B., Rebe, C., Chalmin, F., Vincent, J., Ghiringhelli, Presence of Foxp3 expression in tumor cells predicts better survival in HER2-overexpressing breast cancer patients treated with neoadjuvant chemotherapy (2010) Breast Cancer Res. Treat., 125 (1), pp. 65-72
• Levine, M.N., New antithrombotic drugs: Potential for use in oncology (2009) J. Clin. Oncol., 27 (29), pp. 4912-4918
• Green, D., Karpatkin, S., Role of thrombin as a tumor growth factor (2010) Cell Cycle, 9 (4), pp. 656-661
• Wasylyk, C., Zambrano, A., Zhao, C., Brants, J., Abecassis, J., Schalken, J.A., Rogatsch, H., Wasylyk, B., ubulin tyrosine ligase like 12, link to prostate cancer through tubulin post-translational modification and chromosome ploidy (2010) Int. J. Cancer., 127 (11), pp. 2542-2553
• Dong, X., Guan, J., English, J.C., Flint, J., Yee, J., Evans, K., Murray, N., Wang, Y., Patient-derived first generation xenografts of non-small cell lung cancers: Promising tools for predicting drug responses for personalized chemotherapy (2010) Clin. Cancer Res., 16 (5), pp. 1442-1451

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------